Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer

6392.50
0.50%
ICICI Securities Limited
Divi’s Laboratories’ (Divi’s) Q2FY26 result was in line with our expectations on all fronts. Constant currency growth slowed down to ~10.8% vs. 15% QoQ and 18% in FY25.
Divi's Laboratories Ltd.'s price crossed above 30Day SMA today
More from Divi's Laboratories Ltd.
Recommended